Investigation of circulating lncRNAs in B-cell neoplasms

Clinica Chimica Acta

Volumn 431, Issue , 2014, Pages 255-259

  Isin, Mustafa ^a   Ozgur, Emre ^a   Cetin, Guven ^b   Erten, Nilgun ^c   Aktan, Melih ^c   Gezer, Ugur ^a   Dalay, Nejat ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Bezm i Alem VakIf Gureba University   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cell free RNA; Chronic lymphocytic leukemia; LncRNA; Multiple myeloma

Indexed keywords

LONG UNTRANSLATED RNA; PROTEIN P53; COMPLEMENTARY DNA; PRIMER DNA;

ARTICLE; BLOOD LEVEL; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; GENE EXPRESSION; GROWTH ARREST SPECIFIC 5 GENE; HOX ANTISENSE INTERGENIC RNA GENE; HUMAN; LARGE INTERGENIC NONCODING RNA P21 GENE; MAJOR CLINICAL STUDY; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1 GENE; MULTIPLE MYELOMA; PRIORITY JOURNAL; RNA GENE; TAURINE UPREGULATED GENE 1; B CELL LYMPHOMA; B LYMPHOCYTE; BLOOD; CHEMISTRY; DISEASE COURSE; GENETICS; METABOLISM; POLYMERASE CHAIN REACTION;

B-LYMPHOCYTES; DISEASE PROGRESSION; DNA PRIMERS; DNA, COMPLEMENTARY; HUMANS; LYMPHOMA, B-CELL; MULTIPLE MYELOMA; POLYMERASE CHAIN REACTION; RNA, LONG NONCODING;

EID: 84896040271     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.02.010     Document Type: Article

References (49)

1. Rodríguez-Vicente A.E., Díaz M.G., Hernández-Rivas J.M. Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease. Cancer Genet 2013, 206:49-62.
2. Palumbo A., Anderson K. Multiple myeloma. N Engl J Med 2011, 364:1046-1060.
3. Sanchez Y., Huarte M. Long non-coding RNAs: challenges for diagnosis and therapies. Nucleic Acid Ther 2013, 23:15-20.
4. Mattick J.S. The genetic signatures of noncoding RNAs. PLoS Genet 2009, 5:e1000459.
5. Jia H., Osak M., Bogu G.K., Stanton L.W., Johnson R., Lipovich L. Genome-wide computational identification and manual annotation of human long noncoding RNA genes. RNA 2010, 16:1478-1487.
6. Gibb E.A., Vucic E.A., Enfield K.S., et al. Human cancer long non-coding RNA transcriptomes. PLoS One 2011, 6:e25915.
7. Huarte M., Rinn J.L. Large non-coding RNAs: missing links in cancer?. Hum Mol Genet 2010, 19(R2):R152-R161.
8. Wong B.C., Dennis Lo Y.M. Plasma RNA integrity analysis: methodology and validation. Ann N Y Acad Sci 2006, 1075:174-178.
9. Halicka H.D., Bedner E., Darzynkiewicz Z. Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis. Exp Cell Res 2000, 260:248-256.
10. Ng E.K., Tsui N.B., Lam N.Y., et al. Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin Chem 2002, 48:1212-1217.
11. Gupta R.A., Shah N., Wang K.C., et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464:1071-1076.
12. Wan Y., Chang H.Y. HOTAIR: flight of noncoding RNAs in cancer metastasis. Cell Cycle 2010, 9:3391-3392.
13. Khalil A.M., Guttman M., Huarte M., et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A 2009, 106:11667-11672.
14. Tsai M.C., Manor O., Wan Y., et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010, 329:689-693.
15. Wilusz J.E., Freier S.M., Spector D.L. 3' end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA. Cell 2008, 135:919-932.
16. Lin R., Maeda S., Liu C., Karin M., Edgington T.S. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 2007, 26:851-858.
17. Huarte M., Guttman M., Feldser D., et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010, 142:409-419.
18. Schneider C., King R.M., Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell 1988, 54:787-793.
19. Ozgur E., Mert U., Isin M., Okutan M., Dalay N., Gezer U. Differential expression of long non-coding RNAs during genotoxic stress-induced apoptosis in HeLa and MCF-7 cells. Clin Exp Med 2013, 13:119-126.
20. Muller A.J., Chatterjee S., Teresky A., Levine A.J. The GAS5 gene is disrupted by a frameshift mutation within its longest open reading frame in several inbred mouse strains and maps to murine chromosome 1. Mamm Genome 1998, 9:773-774.
21. Raho G., Barone V., Rossi D., Philipson L., Sorrentino V. The gas 5 gene shows four alternative splicing patterns without coding for a protein. Gene 2000, 256:13-17.
22. Kino T., Hurt D.E., Ichijo T., Nader N., Chrousos G.P. Noncoding RNA GAS5 is a growth arrest and starvation-associated repressor of the glucocorticoid receptor. Sci Signal 2010, 3:8.
23. Mourtada-Maarabouni M., Pickard M.R., Hedge V.L., Farzaneh F., Williams G.T. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 2009, 28:195-208.
24. Williams G.T., Murtada-Maarabouni M., Farzaneh F. A critical role for non-coding RNA GAS5 in growth arrest and rapamycin inhibition in human T-lymphocytes. Biochem Soc Trans 2011, 39:482-486.
25. Ji P., Diederichs S., Wang W., et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003, 22:8031-8041.
26. Gutschner T., Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 2012, 9:703-719.
27. Mathivanan S., Ji H., Simpson R.J. J Proteomics 2010, 73:1907-1920.
28. Derrien T., Johnson R., Bussotti G., et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 2012, 22:1775-1789.
29. Shanafelt T.D., Witzig T.E. Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia. J Clin Oncol 2006, 24:4634-4641.
30. Romanuik T.L., Wang G., Morozowa O., Delaney A., Marra M.A., Sadar M.D. LNCaP Atlas: gene expression associated with in vivo progression to castration recurrent prostate cancer. BMC Med Genomics 2010, 3:43.
31. Qiao H.P., Gao W.S., Huo J.X., Yang Zhan Z.S. Long non-coding RNA GAS5 functions as a tumor suppressor in renal cell carcinoma. Asian Pac J Cancer Prev 2013, 14:1077-1082.
32. Mourtada-Marabouni M., Hasan A.M., Farzaneh F., Williams G.T. Inhibition of human T-cell proliferation by mammalian target of rapamycin (mTOR) antagonists requires noncoding RNA growth-arrest-specific transcript 5 (GAS5). Mol Pharmacol 2010, 78:19-28.
33. Gee H.E., Buffa F.M., Camps C., et al. The small-nucleolar RNAs commonly used for microRNA normalization correlate with tumor pathology and prognosis. Br J Cancer 2011, 104:1168-1177.
34. Young T.L., Matsuda T., Cepko C.L. The non-coding RNA taurine upregulated gene 1 is required for differentiation of the murine retina. Curr Biol 2005, 15:501-512.
35. Han Y., Liu Y., Gui Y., Cai Z. Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder. J Surg Oncol 2013, 107:555-559.
36. Zang Q., Geng P.L., Yin P., Wang X.L., Jia J.P., Yao J. Down-regulation of long non-coding RNA TUG1 inhibits osteosarcoma cell proliferation and promotes apoptosis. Asian Pac J Cancer Prev 2013, 14:2311-2315.
37. Lai M.C., Yang Z., Zhou L., et al. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol 2012, 29:1810-1816.
38. Li L., Feng T., Lian Y., Zhang G., Garen A., Song X. Role of human non-coding RNAs in the control of tumorigenesis. Proc Natl Acad Sci U S A 2009, 106:12956-12961.
39. Schmidt L.H., Spieker T., Koschmieder S., et al. The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J Thorac Oncol 2011, 6:1984-1992.
40. Bernard D., Prasanth K.V., Tripathi V., et al. A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression. EMBO J 2010, 29:3082-3092.
41. Nakagawa S., Ip J.Y., Shioi G., et al. MALAT1 is not an essential component of nuclear speckles in mice. RNA 2012, 18:1487-1499.
42. Tripathi V., Ellis J.D., Shen Z., et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell 2010, 39:925-938.
43. Zong X., Tripathi V., Prasanth K.V. RNA splicing control: yet another gene regulatory role for long nuclear noncoding RNAs. RNA Biol 2011, 8:968-977.
44. Rinn J.L., Kertesz M., Wang J.K., et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007, 129:1311-1323.
45. Geng Y.J., Xie S.L., Li Q., Ma J., Wang G.Y. Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J Int Med Res 2011, 39:2119-2128.
46. Kogo R., Shimamura T., Mimori K., et al. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res 2011, 71:6320-6326.
47. Niinuma T., Suzuki H., Nojima M., et al. Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res 2012, 72:1126-1136.
48. Tang L., Zhang W., Su B., Yu B. Long noncoding RNA HOTAIR is associated with motility, invasion, and metastatic potential of metastatic melanoma. Biomed Res Int 2013, 2013:251098.
49. Tripathi V., Shen Z., Chakraborty A., et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet 2013, 9:e1003368.